As of 2026-03-28, the Relative Valuation of Avanos Medical Inc (AVNS) is (36.10) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.52 USD, the upside of Avanos Medical Inc based on Relative Valuation is -367.0%.
The range of the Relative Valuation is (32.30) - (34.49) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.6x - 31.8x | 26.2x |
| Forward P/E multiples | 17.7x - 22.0x | 19.8x |
| Fair Price | (32.30) - (34.49) | (36.10) |
| Upside | -338.9% - -355.1% | -367.0% |
| Date | P/E |
| 2026-03-26 | -8.83 |
| 2026-03-25 | -8.80 |
| 2026-03-24 | -8.71 |
| 2026-03-23 | -8.55 |
| 2026-03-20 | -8.32 |
| 2026-03-19 | -8.59 |
| 2026-03-18 | -8.59 |
| 2026-03-17 | -8.68 |
| 2026-03-16 | -8.82 |
| 2026-03-13 | -8.73 |
| 2026-03-12 | -8.57 |
| 2026-03-11 | -8.55 |
| 2026-03-10 | -8.36 |
| 2026-03-09 | -8.37 |
| 2026-03-06 | -8.48 |
| 2026-03-05 | -8.80 |
| 2026-03-04 | -8.85 |
| 2026-03-03 | -8.92 |
| 2026-03-02 | -8.92 |
| 2026-02-27 | -8.99 |
| 2026-02-26 | -9.24 |
| 2026-02-25 | -9.16 |
| 2026-02-24 | -8.70 |
| 2026-02-23 | -9.71 |
| 2026-02-20 | -9.86 |
| 2026-02-19 | -9.70 |
| 2026-02-18 | -9.70 |
| 2026-02-17 | -9.51 |
| 2026-02-13 | -9.50 |
| 2026-02-12 | -9.41 |
| 2026-02-11 | -9.64 |
| 2026-02-10 | -9.39 |
| 2026-02-09 | -9.09 |
| 2026-02-06 | -9.31 |
| 2026-02-05 | -8.83 |
| 2026-02-04 | -8.87 |
| 2026-02-03 | -8.56 |
| 2026-02-02 | -8.59 |
| 2026-01-30 | -8.50 |
| 2026-01-29 | -8.22 |
| 2026-01-28 | -8.20 |
| 2026-01-27 | -8.39 |
| 2026-01-26 | -8.39 |
| 2026-01-23 | -8.35 |
| 2026-01-22 | -8.36 |
| 2026-01-21 | -8.20 |
| 2026-01-20 | -7.88 |
| 2026-01-16 | -7.87 |
| 2026-01-15 | -7.87 |
| 2026-01-14 | -7.57 |